Home/Inapill/Greg Timblin, PhD

GT

Greg Timblin, PhD

Founder & CEO

Therapeutic Areas

Inflammatory Diseases Autoimmune Diseases Age-related Diseases

Inapill Pipeline

Drug	Indication	Phase
Undisclosed Immunometabolism Program(s)	Inflammatory/Autoimmune Diseases	Preclinical

Leadership Team at Inapill

Scientist, Protein Biochemist

Kathleen Pestal, PhD

Scientist, Immunology

View full Inapill profile